REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/16/2025
Back to search
Official data from USPTO
ILITE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ILITE
ST13
US500000079243106Class
1, 5, 9, 10, 42, 44
Filing
79243106
Registration
6077015
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
06/17/2025
Trademark type
Word
Nice classes
1, 5, 9, 10, 42, 44
Filing date
06/05/2018
Registration date
06/16/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2020
Last transaction
06/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
SE
Examiner
RUTLAND, BARBARA
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SVAR Life Science AB
Representatives
Gregory J. Chinlund MARSHALL, GERSTEIN & BORUN LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Substances for use in cell-based reporter gene assaysassays for research purposes; reagents for medical research purposes; reagents for research purposes; reagents for industrial purposesreagents for scientific and research use; reagents for chemical analyseschemical reagents for non-medical purposes; cells and reagents for scientific and research use in testing of pharmaceutical products; cell culture media for scientific and research usecell lines; components for cell-based analyses using optical methods and containing chemical reagentscells for scientific and research use
Class 5
Reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use
Class 9
Laboratory apparatus in the nature of instruments for use in performing cell-based assays by means of optic detectionoptical quantification apparatus; computer software for use in optic based biological analysis; computer software for use in optic based biological analysis such as tools and methods used during drug developmentclinical diagnosisclinical monitoring or assay development
Class 10
Medical diagnostic apparatus for use in testing assays
Class 42
Cell-based assay servicescustom design and development of cell-based biochemical assays; cell-based assay servicescustom design and development of cell-based biochemical assays for use in drug developmentclinical diagnosisclinical monitoring or assay development; medical research; clinical research in the field of drug developmentclinical diagnosisclinical monitoring or assay development; scientific research; research and development in the field of diagnostic preparations; pharmaceutical drug development services; conducting clinical trials for others; scientificmedical laboratory research and analysis services; scientific and medical laboratory testing services
Class 44
Medical testing services relating to measurement and quantification of drug levels and immunogenicity in patient samples for diagnostic or treatment purposes; medical servicestreating persons based on laboratory analysis; providing medical support in the nature of medical monitoring of patients receiving medical treatments; medical diagnostic testing services
Publications
History of USPTO decisions and trademark events.
45 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/07/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/25/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/03/2020
FIMP
FINAL DISPOSITION PROCESSED
10/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/16/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/15/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/29/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/29/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2020
PUBO
PUBLISHED FOR OPPOSITION
03/31/2020
GPNX
NOTIFICATION PROCESSED BY IB
03/27/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/11/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/11/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/25/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/13/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/10/2020
GNSL
LETTER OF SUSPENSION E-MAILED
01/10/2020
CNSL
SUSPENSION LETTER WRITTEN
01/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/21/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2019
RFNT
REFUSAL PROCESSED BY IB
08/23/2019
CNRT
NON-FINAL ACTION MAILED
06/26/2019
CNRT
NON-FINAL ACTION WRITTEN
06/26/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2019
ALIE
ASSIGNED TO LIE
06/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/30/2019
RFNT
REFUSAL PROCESSED BY IB
03/29/2019
CNRT
NON-FINAL ACTION MAILED
01/18/2019
CNRT
NON-FINAL ACTION WRITTEN
01/16/2019
RFNT
REFUSAL PROCESSED BY IB
12/21/2018
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
12/13/2018
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
11/30/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/13/2018
RFRR
REFUSAL PROCESSED BY MPU
11/13/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/27/2018
CNRT
NON-FINAL ACTION WRITTEN
10/26/2018
MAFR
APPLICATION FILING RECEIPT MAILED
10/23/2018
DOCK
ASSIGNED TO EXAMINER
10/19/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/19/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/18/2018
Continuous trademark protection
Get notified about every new filing that threatens ILITE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.